An ‘insane’ calculus: A pharma company raised price for a rare disease drug 150% to cover Medicaid rebates Eton Pharmaceuticals says there was no other way to keep its therapy on the market, turn a profit

https://www.statnews.com/pharmalot/2025/04/22/pharma-medicine-rebate-medicaid-rare-disease/